Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 707

1.

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

Källén BA, Otterblad Olausson P.

Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8.

PMID:
17216624
2.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
3.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
4.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
5.

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

Wogelius P, Nørgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, Lipworth L, Sørensen HT.

Epidemiology. 2006 Nov;17(6):701-4.

PMID:
17028507
6.

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study.

N Engl J Med. 2007 Jun 28;356(26):2684-92.

7.

Maternal use of antipsychotics in early pregnancy and delivery outcome.

Reis M, Källén B.

J Clin Psychopharmacol. 2008 Jun;28(3):279-88. doi: 10.1097/JCP.0b013e318172b8d5.

PMID:
18480684
8.

Duration of antidepressant use during pregnancy and risk of major congenital malformations.

Ramos E, St-André M, Rey E, Oraichi D, Bérard A.

Br J Psychiatry. 2008 May;192(5):344-50. doi: 10.1192/bjp.bp.107.042523.

9.

Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants.

Källén B, Otterblad Olausson P.

Eur J Clin Pharmacol. 2007 Apr;63(4):383-8. Epub 2007 Feb 6.

PMID:
17279357
10.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
11.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
12.

Delivery outcome in relation to maternal use of some recently introduced antidepressants.

Lennestål R, Källén B.

J Clin Psychopharmacol. 2007 Dec;27(6):607-13.

PMID:
18004128
13.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
14.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
15.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
16.

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn.

Källén B, Olausson PO.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):801-6. doi: 10.1002/pds.1570.

PMID:
18314924
17.

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.

Br J Clin Pharmacol. 2008 Apr;65(4):600-6. Epub 2007 Oct 22.

18.

Paroxetine in the first trimester and the prevalence of congenital malformations.

Cole JA, Ephross SA, Cosmatos IS, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1075-85.

PMID:
17729379
19.

Early pregnancy azathioprine use and pregnancy outcomes.

Cleary BJ, Källén B.

Birth Defects Res A Clin Mol Teratol. 2009 Jul;85(7):647-54. doi: 10.1002/bdra.20583.

PMID:
19343728
20.

Maternal obesity and morbid obesity: the risk for birth defects in the offspring.

Blomberg MI, Källén B.

Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):35-40. doi: 10.1002/bdra.20620.

PMID:
19711433
Items per page

Supplemental Content

Write to the Help Desk